HEADER MEMBRANE PROTEIN,TRANSFERASE 16-OCT-19 6L47 TITLE STRUCTURE OF THE HUMAN STEROL O-ACYLTRANSFERASE 1 IN COMPLEX WITH CI- TITLE 2 976 COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROL O-ACYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ACYL-COENZYME A:CHOLESTEROL ACYLTRANSFERASE 1,ACAT-1, COMPND 5 CHOLESTEROL ACYLTRANSFERASE 1; COMPND 6 EC: 2.3.1.26; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SOAT1, ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SOAT, ACAT, MBOAT, MEMBRANE PROTEIN, TRANSFERASE EXPDTA ELECTRON MICROSCOPY AUTHOR L.CHEN,C.GUAN,Y.NIU REVDAT 2 07-OCT-20 6L47 1 JRNL REVDAT 1 29-APR-20 6L47 0 JRNL AUTH C.GUAN,Y.NIU,S.C.CHEN,Y.KANG,J.X.WU,K.NISHI,C.C.Y.CHANG, JRNL AUTH 2 T.Y.CHANG,T.LUO,L.CHEN JRNL TITL STRUCTURAL INSIGHTS INTO THE INHIBITION MECHANISM OF HUMAN JRNL TITL 2 STEROL O-ACYLTRANSFERASE 1 BY A COMPETITIVE INHIBITOR. JRNL REF NAT COMMUN V. 11 2478 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32424158 JRNL DOI 10.1038/S41467-020-16288-4 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CISTEM REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.500 REMARK 3 NUMBER OF PARTICLES : 222018 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: CISTEM RESOLUTION LIMITING METHODS REMARK 4 REMARK 4 6L47 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1300014163. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN STEROL O-ACYLTRANSFERASE REMARK 245 1 DIMER REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 50.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 66 REMARK 465 LYS A 67 REMARK 465 GLU A 68 REMARK 465 VAL A 69 REMARK 465 GLY A 70 REMARK 465 SER A 71 REMARK 465 HIS A 72 REMARK 465 PHE A 73 REMARK 465 ASP A 74 REMARK 465 ASP A 75 REMARK 465 PHE A 76 REMARK 465 VAL A 77 REMARK 465 THR A 78 REMARK 465 ASN A 79 REMARK 465 LEU A 80 REMARK 465 ILE A 81 REMARK 465 GLU A 82 REMARK 465 LYS A 83 REMARK 465 SER A 84 REMARK 465 ALA A 85 REMARK 465 SER A 86 REMARK 465 LEU A 87 REMARK 465 ASP A 88 REMARK 465 ASN A 89 REMARK 465 GLY A 90 REMARK 465 GLY A 91 REMARK 465 CYS A 92 REMARK 465 ALA A 93 REMARK 465 LEU A 94 REMARK 465 THR A 95 REMARK 465 THR A 96 REMARK 465 PHE A 97 REMARK 465 SER A 98 REMARK 465 VAL A 99 REMARK 465 LEU A 100 REMARK 465 GLU A 101 REMARK 465 GLY A 102 REMARK 465 GLU A 103 REMARK 465 LYS A 104 REMARK 465 ASN A 105 REMARK 465 ASN A 106 REMARK 465 HIS A 107 REMARK 465 ARG A 108 REMARK 465 ALA A 109 REMARK 465 LYS A 110 REMARK 465 ASP A 111 REMARK 465 LEU A 112 REMARK 465 ARG A 113 REMARK 465 ALA A 114 REMARK 465 PRO A 115 REMARK 465 PRO A 116 REMARK 465 GLU A 117 REMARK 465 ILE A 489 REMARK 465 VAL A 490 REMARK 465 ASN A 491 REMARK 465 ASP A 492 REMARK 465 SER A 493 REMARK 465 ARG A 494 REMARK 465 LYS A 495 REMARK 465 LYS A 496 REMARK 465 ASN A 534 REMARK 465 PRO A 535 REMARK 465 THR A 536 REMARK 465 PHE A 537 REMARK 465 LEU A 538 REMARK 465 ARG A 549 REMARK 465 TYR A 550 REMARK 465 VAL A 551 REMARK 465 PHE A 552 REMARK 465 MET B 66 REMARK 465 LYS B 67 REMARK 465 GLU B 68 REMARK 465 VAL B 69 REMARK 465 GLY B 70 REMARK 465 SER B 71 REMARK 465 HIS B 72 REMARK 465 PHE B 73 REMARK 465 ASP B 74 REMARK 465 ASP B 75 REMARK 465 PHE B 76 REMARK 465 VAL B 77 REMARK 465 THR B 78 REMARK 465 ASN B 79 REMARK 465 LEU B 80 REMARK 465 ILE B 81 REMARK 465 GLU B 82 REMARK 465 LYS B 83 REMARK 465 SER B 84 REMARK 465 ALA B 85 REMARK 465 SER B 86 REMARK 465 LEU B 87 REMARK 465 ASP B 88 REMARK 465 ASN B 89 REMARK 465 GLY B 90 REMARK 465 GLY B 91 REMARK 465 CYS B 92 REMARK 465 ALA B 93 REMARK 465 LEU B 94 REMARK 465 THR B 95 REMARK 465 THR B 96 REMARK 465 PHE B 97 REMARK 465 SER B 98 REMARK 465 VAL B 99 REMARK 465 LEU B 100 REMARK 465 GLU B 101 REMARK 465 GLY B 102 REMARK 465 GLU B 103 REMARK 465 LYS B 104 REMARK 465 ASN B 105 REMARK 465 ASN B 106 REMARK 465 HIS B 107 REMARK 465 ARG B 108 REMARK 465 ALA B 109 REMARK 465 LYS B 110 REMARK 465 ASP B 111 REMARK 465 LEU B 112 REMARK 465 ARG B 113 REMARK 465 ALA B 114 REMARK 465 PRO B 115 REMARK 465 PRO B 116 REMARK 465 GLU B 117 REMARK 465 ILE B 489 REMARK 465 VAL B 490 REMARK 465 ASN B 491 REMARK 465 ASP B 492 REMARK 465 SER B 493 REMARK 465 ARG B 494 REMARK 465 LYS B 495 REMARK 465 LYS B 496 REMARK 465 ASN B 534 REMARK 465 PRO B 535 REMARK 465 THR B 536 REMARK 465 PHE B 537 REMARK 465 LEU B 538 REMARK 465 ARG B 549 REMARK 465 TYR B 550 REMARK 465 VAL B 551 REMARK 465 PHE B 552 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 ARG A 166 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 170 CG CD OE1 OE2 REMARK 470 ARG A 219 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 237 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 ASP A 310 CG OD1 OD2 REMARK 470 LYS A 353 CG CD CE NZ REMARK 470 GLN A 354 CG CD OE1 NE2 REMARK 470 ASP A 400 CG OD1 OD2 REMARK 470 ARG A 401 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 444 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 461 CG CD OE1 OE2 REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 ARG A 542 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 544 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 118 CG CD OE1 NE2 REMARK 470 ARG B 166 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 170 CG CD OE1 OE2 REMARK 470 ARG B 219 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 237 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 ASP B 310 CG OD1 OD2 REMARK 470 LYS B 353 CG CD CE NZ REMARK 470 GLN B 354 CG CD OE1 NE2 REMARK 470 ASP B 400 CG OD1 OD2 REMARK 470 ARG B 401 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 444 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 461 CG CD OE1 OE2 REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 ARG B 542 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 544 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 166 -169.80 -166.72 REMARK 500 LEU A 169 67.50 62.93 REMARK 500 SER A 197 -60.80 -90.85 REMARK 500 SER A 214 -170.27 -67.15 REMARK 500 HIS A 215 109.26 -45.94 REMARK 500 ARG A 309 90.70 -69.27 REMARK 500 GLU A 355 107.92 -47.51 REMARK 500 ASP A 400 33.42 -94.14 REMARK 500 TYR A 404 128.02 -171.38 REMARK 500 TYR A 472 104.46 -54.72 REMARK 500 PRO A 473 57.18 -94.01 REMARK 500 ARG A 544 10.91 59.19 REMARK 500 ARG B 166 -169.81 -166.71 REMARK 500 LEU B 169 67.56 62.91 REMARK 500 SER B 197 -60.77 -90.87 REMARK 500 SER B 214 -170.30 -67.20 REMARK 500 HIS B 215 109.27 -45.97 REMARK 500 ARG B 309 90.75 -69.25 REMARK 500 GLU B 355 107.89 -47.48 REMARK 500 ASP B 400 33.45 -94.15 REMARK 500 TYR B 404 128.01 -171.40 REMARK 500 TYR B 472 104.41 -54.71 REMARK 500 PRO B 473 57.24 -94.01 REMARK 500 ARG B 544 10.97 59.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E5L A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CLR A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E5L B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CLR B 1002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-0831 RELATED DB: EMDB REMARK 900 STRUCTURE OF THE HUMAN STEROL O-ACYLTRANSFERASE 1 IN COMPLEX WITH REMARK 900 CI-976 DBREF 6L47 A 66 552 UNP P35610 SOAT1_HUMAN 66 550 DBREF 6L47 B 66 552 UNP P35610 SOAT1_HUMAN 66 550 SEQRES 1 A 485 MET LYS GLU VAL GLY SER HIS PHE ASP ASP PHE VAL THR SEQRES 2 A 485 ASN LEU ILE GLU LYS SER ALA SER LEU ASP ASN GLY GLY SEQRES 3 A 485 CYS ALA LEU THR THR PHE SER VAL LEU GLU GLY GLU LYS SEQRES 4 A 485 ASN ASN HIS ARG ALA LYS ASP LEU ARG ALA PRO PRO GLU SEQRES 5 A 485 GLN GLY LYS ILE PHE ILE ALA ARG ARG SER LEU LEU ASP SEQRES 6 A 485 GLU LEU LEU GLU VAL ASP HIS ILE ARG THR ILE TYR HIS SEQRES 7 A 485 MET PHE ILE ALA LEU LEU ILE LEU PHE ILE LEU SER THR SEQRES 8 A 485 LEU VAL VAL ASP TYR ILE ASP GLU GLY ARG LEU VAL LEU SEQRES 9 A 485 GLU PHE SER LEU LEU SER TYR ALA PHE GLY LYS PHE PRO SEQRES 10 A 485 THR VAL VAL TRP THR TRP TRP ILE MET PHE LEU SER THR SEQRES 11 A 485 PHE SER VAL PRO TYR PHE LEU PHE GLN HIS TRP ALA THR SEQRES 12 A 485 GLY TYR SER LYS SER SER HIS PRO LEU ILE ARG SER LEU SEQRES 13 A 485 PHE HIS GLY PHE LEU PHE MET ILE PHE GLN ILE GLY VAL SEQRES 14 A 485 LEU GLY PHE GLY PRO THR TYR VAL VAL LEU ALA TYR THR SEQRES 15 A 485 LEU PRO PRO ALA SER ARG PHE ILE ILE ILE PHE GLU GLN SEQRES 16 A 485 ILE ARG PHE VAL MET LYS ALA HIS SER PHE VAL ARG GLU SEQRES 17 A 485 ASN VAL PRO ARG VAL LEU ASN SER ALA LYS GLU LYS SER SEQRES 18 A 485 SER THR VAL PRO ILE PRO THR VAL ASN GLN TYR LEU TYR SEQRES 19 A 485 PHE LEU PHE ALA PRO THR LEU ILE TYR ARG ASP SER TYR SEQRES 20 A 485 PRO ARG ASN PRO THR VAL ARG TRP GLY TYR VAL ALA MET SEQRES 21 A 485 LYS PHE ALA GLN VAL PHE GLY CYS PHE PHE TYR VAL TYR SEQRES 22 A 485 TYR ILE PHE GLU ARG LEU CYS ALA PRO LEU PHE ARG ASN SEQRES 23 A 485 ILE LYS GLN GLU PRO PHE SER ALA ARG VAL LEU VAL LEU SEQRES 24 A 485 CYS VAL PHE ASN SER ILE LEU PRO GLY VAL LEU ILE LEU SEQRES 25 A 485 PHE LEU THR PHE PHE ALA PHE LEU HIS CYS TRP LEU ASN SEQRES 26 A 485 ALA PHE ALA GLU MET LEU ARG PHE GLY ASP ARG MET PHE SEQRES 27 A 485 TYR LYS ASP TRP TRP ASN SER THR SER TYR SER ASN TYR SEQRES 28 A 485 TYR ARG THR TRP ASN VAL VAL VAL HIS ASP TRP LEU TYR SEQRES 29 A 485 TYR TYR ALA TYR LYS ASP PHE LEU TRP PHE PHE SER LYS SEQRES 30 A 485 ARG PHE LYS SER ALA ALA MET LEU ALA VAL PHE ALA VAL SEQRES 31 A 485 SER ALA VAL VAL HIS GLU TYR ALA LEU ALA VAL CYS LEU SEQRES 32 A 485 SER PHE PHE TYR PRO VAL LEU PHE VAL LEU PHE MET PHE SEQRES 33 A 485 PHE GLY MET ALA PHE ASN PHE ILE VAL ASN ASP SER ARG SEQRES 34 A 485 LYS LYS PRO ILE TRP ASN VAL LEU MET TRP THR SER LEU SEQRES 35 A 485 PHE LEU GLY ASN GLY VAL LEU LEU CYS PHE TYR SER GLN SEQRES 36 A 485 GLU TRP TYR ALA ARG GLN HIS CYS PRO LEU LYS ASN PRO SEQRES 37 A 485 THR PHE LEU ASP TYR VAL ARG PRO ARG SER TRP THR CYS SEQRES 38 A 485 ARG TYR VAL PHE SEQRES 1 B 485 MET LYS GLU VAL GLY SER HIS PHE ASP ASP PHE VAL THR SEQRES 2 B 485 ASN LEU ILE GLU LYS SER ALA SER LEU ASP ASN GLY GLY SEQRES 3 B 485 CYS ALA LEU THR THR PHE SER VAL LEU GLU GLY GLU LYS SEQRES 4 B 485 ASN ASN HIS ARG ALA LYS ASP LEU ARG ALA PRO PRO GLU SEQRES 5 B 485 GLN GLY LYS ILE PHE ILE ALA ARG ARG SER LEU LEU ASP SEQRES 6 B 485 GLU LEU LEU GLU VAL ASP HIS ILE ARG THR ILE TYR HIS SEQRES 7 B 485 MET PHE ILE ALA LEU LEU ILE LEU PHE ILE LEU SER THR SEQRES 8 B 485 LEU VAL VAL ASP TYR ILE ASP GLU GLY ARG LEU VAL LEU SEQRES 9 B 485 GLU PHE SER LEU LEU SER TYR ALA PHE GLY LYS PHE PRO SEQRES 10 B 485 THR VAL VAL TRP THR TRP TRP ILE MET PHE LEU SER THR SEQRES 11 B 485 PHE SER VAL PRO TYR PHE LEU PHE GLN HIS TRP ALA THR SEQRES 12 B 485 GLY TYR SER LYS SER SER HIS PRO LEU ILE ARG SER LEU SEQRES 13 B 485 PHE HIS GLY PHE LEU PHE MET ILE PHE GLN ILE GLY VAL SEQRES 14 B 485 LEU GLY PHE GLY PRO THR TYR VAL VAL LEU ALA TYR THR SEQRES 15 B 485 LEU PRO PRO ALA SER ARG PHE ILE ILE ILE PHE GLU GLN SEQRES 16 B 485 ILE ARG PHE VAL MET LYS ALA HIS SER PHE VAL ARG GLU SEQRES 17 B 485 ASN VAL PRO ARG VAL LEU ASN SER ALA LYS GLU LYS SER SEQRES 18 B 485 SER THR VAL PRO ILE PRO THR VAL ASN GLN TYR LEU TYR SEQRES 19 B 485 PHE LEU PHE ALA PRO THR LEU ILE TYR ARG ASP SER TYR SEQRES 20 B 485 PRO ARG ASN PRO THR VAL ARG TRP GLY TYR VAL ALA MET SEQRES 21 B 485 LYS PHE ALA GLN VAL PHE GLY CYS PHE PHE TYR VAL TYR SEQRES 22 B 485 TYR ILE PHE GLU ARG LEU CYS ALA PRO LEU PHE ARG ASN SEQRES 23 B 485 ILE LYS GLN GLU PRO PHE SER ALA ARG VAL LEU VAL LEU SEQRES 24 B 485 CYS VAL PHE ASN SER ILE LEU PRO GLY VAL LEU ILE LEU SEQRES 25 B 485 PHE LEU THR PHE PHE ALA PHE LEU HIS CYS TRP LEU ASN SEQRES 26 B 485 ALA PHE ALA GLU MET LEU ARG PHE GLY ASP ARG MET PHE SEQRES 27 B 485 TYR LYS ASP TRP TRP ASN SER THR SER TYR SER ASN TYR SEQRES 28 B 485 TYR ARG THR TRP ASN VAL VAL VAL HIS ASP TRP LEU TYR SEQRES 29 B 485 TYR TYR ALA TYR LYS ASP PHE LEU TRP PHE PHE SER LYS SEQRES 30 B 485 ARG PHE LYS SER ALA ALA MET LEU ALA VAL PHE ALA VAL SEQRES 31 B 485 SER ALA VAL VAL HIS GLU TYR ALA LEU ALA VAL CYS LEU SEQRES 32 B 485 SER PHE PHE TYR PRO VAL LEU PHE VAL LEU PHE MET PHE SEQRES 33 B 485 PHE GLY MET ALA PHE ASN PHE ILE VAL ASN ASP SER ARG SEQRES 34 B 485 LYS LYS PRO ILE TRP ASN VAL LEU MET TRP THR SER LEU SEQRES 35 B 485 PHE LEU GLY ASN GLY VAL LEU LEU CYS PHE TYR SER GLN SEQRES 36 B 485 GLU TRP TYR ALA ARG GLN HIS CYS PRO LEU LYS ASN PRO SEQRES 37 B 485 THR PHE LEU ASP TYR VAL ARG PRO ARG SER TRP THR CYS SEQRES 38 B 485 ARG TYR VAL PHE HET E5L A1001 28 HET CLR A1002 28 HET E5L B1001 28 HET CLR B1002 28 HETNAM E5L 2,2-DIMETHYL-N-(2,4,6-TRIMETHOXYPHENYL)DODECANAMIDE HETNAM CLR CHOLESTEROL FORMUL 3 E5L 2(C23 H39 N O4) FORMUL 4 CLR 2(C27 H46 O) HELIX 1 AA1 SER A 127 LEU A 133 1 7 HELIX 2 AA2 VAL A 135 GLY A 165 1 31 HELIX 3 AA3 SER A 172 PHE A 178 1 7 HELIX 4 AA4 LYS A 180 SER A 213 1 34 HELIX 5 AA5 PRO A 216 THR A 247 1 32 HELIX 6 AA6 PRO A 249 LYS A 285 1 37 HELIX 7 AA7 THR A 293 LEU A 301 1 9 HELIX 8 AA8 ARG A 319 ALA A 346 1 28 HELIX 9 AA9 SER A 358 SER A 369 1 12 HELIX 10 AB1 SER A 369 MET A 395 1 27 HELIX 11 AB2 SER A 412 THR A 419 1 8 HELIX 12 AB3 ASN A 421 PHE A 439 1 19 HELIX 13 AB4 SER A 446 CYS A 467 1 22 HELIX 14 AB5 PRO A 473 ASN A 487 1 15 HELIX 15 AB6 ILE A 498 CYS A 528 1 31 HELIX 16 AB7 SER B 127 LEU B 133 1 7 HELIX 17 AB8 VAL B 135 GLY B 165 1 31 HELIX 18 AB9 SER B 172 PHE B 178 1 7 HELIX 19 AC1 LYS B 180 SER B 213 1 34 HELIX 20 AC2 PRO B 216 THR B 247 1 32 HELIX 21 AC3 PRO B 249 LYS B 285 1 37 HELIX 22 AC4 THR B 293 LEU B 301 1 9 HELIX 23 AC5 ARG B 319 ALA B 346 1 28 HELIX 24 AC6 SER B 358 SER B 369 1 12 HELIX 25 AC7 SER B 369 MET B 395 1 27 HELIX 26 AC8 SER B 412 THR B 419 1 8 HELIX 27 AC9 ASN B 421 PHE B 439 1 19 HELIX 28 AD1 SER B 446 CYS B 467 1 22 HELIX 29 AD2 PRO B 473 ASN B 487 1 15 HELIX 30 AD3 ILE B 498 CYS B 528 1 31 SSBOND 1 CYS A 365 CYS A 516 1555 1555 2.06 SSBOND 2 CYS A 528 CYS A 548 1555 1555 2.03 SSBOND 3 CYS B 365 CYS B 516 1555 1555 2.06 SSBOND 4 CYS B 528 CYS B 548 1555 1555 2.03 SITE 1 AC1 7 TYR A 416 TYR A 417 TRP A 420 ASN A 421 SITE 2 AC1 7 VAL A 424 HIS A 460 ASN A 511 SITE 1 AC2 13 ILE A 138 TYR A 142 PHE A 145 ILE A 146 SITE 2 AC2 13 CYS A 333 TYR A 336 PHE A 378 LEU A 379 SITE 3 AC2 13 PHE A 382 TRP A 408 HIS B 137 THR B 140 SITE 4 AC2 13 ILE B 141 SITE 1 AC3 7 TYR B 416 TYR B 417 TRP B 420 ASN B 421 SITE 2 AC3 7 VAL B 424 HIS B 460 ASN B 511 SITE 1 AC4 13 HIS A 137 THR A 140 ILE A 141 ILE B 138 SITE 2 AC4 13 TYR B 142 PHE B 145 ILE B 146 CYS B 333 SITE 3 AC4 13 TYR B 336 PHE B 378 LEU B 379 PHE B 382 SITE 4 AC4 13 TRP B 408 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000